Knobbe Martens Olson & Bear

Practice Areas | News | Patent | Vault Profile | NALP

Rating are based on thousands of associate surveys.

Main Office: Irvine
Participating Offices: N/A
Prestige [?]: N/A
Compensation [?]: N/A
Hours worked [?]: N/A
Place to stay [?]: N/A
Lifestyle [?]: N/A
Progression potential [?]: N/A
Diversity commitment [?]: N/A
Pro Bono dedication [?]: N/A
User rating [?]:

Write a comment about this firm and share your views.

Most useful comments (See all comments)

No comments have yet been rated as useful.

Most recent comments (See all comments)

There are no comments.

Ratings principally based on over 6,500 associate surveys (3rd-5th years). See The American Lawyer's 2006 Midlevel Associates Survey.

Firm News

Knobbe Martens Client Nomadix Prevails On Summary JudgmentJD Supra (press release)Nomadix is a leading provider of intelligent network devices, and offers solutions for secure wireless computing, bandwidth management, visitor-based networks and public Internet access. Knobbe Martens filed a patent infringement suit on behalf of …and more »
2015 IP Law Year In ReviewJD Supra (press release).....Does a defendant's belief that a patent is invalid serve as a defense to charges of inducing infringement? NO - ..Inducement requires proof that the accused: – (1) knows of the patent-in-suit, and. – (2) knows that the actions induced constitute …and more »
HeartWare Cancels $930M Deal with Valtech CardioJD Supra (press release)HeartWare International, Inc. has announced that it will not longer proceed with its previously announced deal to acquire Valtech Cardio, Ltd. Valtech is a privately held Israeli company developing transcatheter mitral and tricuspid replacement and …
JD Supra (press release)
Federal Circuit Review | January 2016JD Supra (press release)In Merck & Cie v. Gnosis S.p.A., Appeal No. 2014-1779, the Federal Circuit affirmed a PTAB IPR decision finding that the instituted claims were invalid as obvious. The PTAB instituted an IPR of patent claims directed toward methods of using folates to …and more »
JD Supra (press release)
Medtronic Launches FDA-Cleared OsteoCool RF Ablation SystemJD Supra (press release)According to Medtronic, the OsteoCool RF Ablation System has received U.S. Food and Drug Administration (FDA) 510(k) clearance and they are launching the device in the United States. However, this news may not be surprising to some. According to ...
Trademark Review | January 2016JD Supra (press release)The U.S. Court of Appeals for the Federal Circuit, sitting en banc, issued a ruling that Section 2(a) of the Lanham Act violates the First Amendment because it prohibits registration of a “disparaging” trademark. The appeal was brought by the members …and more »
FDA Proposes Public Notification of “Emerging Signals”JD Supra (press release)The Food and Drug Administration has proposed a new policy for earlier public notification of medical device safety issues. These notifications will be in addition to the recall notices, safety communications, and press releases the FDA already puts out.and more »
JD Supra (press release)
NuVasive To Acquire Ellipse TechnologiesJD Supra (press release)In a recent press release, San Diego, California-based NuVasive, Inc. nuvasive-logo-2005 announced that it will acquire Ellipse Technologies, Inc. (“Ellipse”), a privately held medical technology company based in Aliso Viejo, California. According to …
FTC Approves Tornier and Wright Medical MergerJD Supra (press release)The U.S. Federal Trade Commission (FTC) recently issued a final order that conditionally approves the merger between Amsterdam, Netherlands-based Tornier N.V. and Memphis, Tennessee-based Wright · Tornier Medical Group, Inc. Reuters reports that the ...
How can patents survive IPRs with all claims intact?InsideCounselIP firm Knobbe Martens scored a win for client STAR EnviroTech at the end of 2015 when the U.S. Court of Appeals for the Federal Circuit affirmed a PTAB decision upholding the validity of a STAR patent in a precedent-setting 33-page opinion. The patent ...and more »
Valid XHTML 1.0 Transitional
Valid CSS!